WeChat Mini Program
Old Version Features

Longer Term Follow-up of a Multicenter, Phase 2 Study of Ibrutinib Plus Fludarabine, Cyclophosphamide, Rituximab (ifcr) As Initial Therapy for Younger Patients with Chronic Lymphocytic Leukemia

Matthew S. Davids,Danielle M. Brander,Svitlana Tyekucheva,Chinheng Chen,James Kaminski,Josie Montegaard,Alvaro J. Alencar,Mohammad Omaira,Caron Jacobson,Philippe Armand,Samuel Y. Ng,Jennifer L. Crombie,Ann S. LaCasce,Jon E. Arnason,Ephraim Hochberg,Ronald W. Takvorian,Jeremy S. Abramson,David C. Fisher,Jennifer R. Brown

Blood（2021）

Cited 3|Views33
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined